Expect more biosimilar education from industry group

Biosimilar manufacturers have been given $5 million by the federal government for campaigns to encourage clinicians to prescribe cheaper versions of agents such as infliximab. A $5 million federal government grant under the Biosimilar Awareness Initiative has been awarded to a new educational arm of the Generic and Biosimilar Medicines Association (GBMA). The funding assigned ...

Already a member?

Login to keep reading.

© 2021 the limbic